• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Ten-year experience with cryopreserved vascular allografts in the Croatian Cardiovascular Tissue Bank.克罗地亚心血管组织库中冷冻保存血管同种异体移植物的十年经验。
Cell Tissue Bank. 2022 Dec;23(4):807-824. doi: 10.1007/s10561-022-09992-6. Epub 2022 Feb 7.
2
Cryopreserved human heart valve allografts: a ten-year single centre experience.冷冻保存的人心脏瓣膜同种异体移植物:十年单中心经验。
Cell Tissue Bank. 2023 Jun;24(2):401-416. doi: 10.1007/s10561-022-10043-3. Epub 2022 Oct 12.
3
Arterial reconstruction with cryopreserved human allografts in the setting of infection: A single-center experience with midterm follow-up.感染情况下使用低温保存的人同种异体移植物进行动脉重建:单中心中期随访经验。
J Vasc Surg. 2009 Mar;49(3):660-6. doi: 10.1016/j.jvs.2008.10.026.
4
In situ reconstruction in native and prosthetic aortic infections using cryopreserved arterial allografts.使用冷冻保存的动脉同种异体移植物原位重建原发性和假体主动脉感染。
Eur J Vasc Endovasc Surg. 2014 Sep;48(3):292-9. doi: 10.1016/j.ejvs.2014.04.023. Epub 2014 Jun 10.
5
Peripheral artery reconstructions using cryopreserved arterial allografts in infected fields.使用冷冻保存的动脉同种异体移植物进行感染部位的外周动脉重建。
J Vasc Surg. 2019 Aug;70(2):562-568. doi: 10.1016/j.jvs.2018.10.111. Epub 2019 Feb 6.
6
Cryopreserved Allograft in the Management of Native and Prosthetic Aortic Infections.低温保存同种异体移植物在天然和人工主动脉感染管理中的应用
Ann Vasc Surg. 2019 Apr;56:1-10. doi: 10.1016/j.avsg.2018.09.010. Epub 2018 Nov 27.
7
Treatment of vascular graft infection by in situ replacement with cryopreserved aortic allografts: an experimental study.采用冷冻保存的主动脉同种异体移植物原位置换治疗血管移植物感染:一项实验研究。
J Vasc Surg. 1998 Apr;27(4):689-98. doi: 10.1016/s0741-5214(98)70235-6.
8
Cryopreserved arterial allografts vs rifampin-soaked Dacron for the treatment of infected aortic and iliac grafts.冷冻保存的动脉同种异体移植物与利福平浸泡的 Dacron 治疗感染的主动脉和髂动脉移植物。
J Vasc Surg. 2023 Oct;78(4):1064-1073.e1. doi: 10.1016/j.jvs.2023.05.048. Epub 2023 Jun 17.
9
Cryopreserved arterial allografts for in situ reconstruction of abdominal aortic native or secondary graft infection.冷冻保存的动脉同种异体移植物原位重建腹主动脉原发或继发性移植物感染。
J Vasc Surg. 2018 Feb;67(2):468-477. doi: 10.1016/j.jvs.2017.06.088. Epub 2017 Aug 18.
10
Cryopreserved Venous Allografts in Supra-inguinal Reconstructions: A Single Centre Experience.冷冻保存的静脉同种异体移植物在股部以上重建中的应用:单中心经验。
Eur J Vasc Endovasc Surg. 2019 Dec;58(6):912-919. doi: 10.1016/j.ejvs.2019.06.024. Epub 2019 Oct 17.

引用本文的文献

1
Multi-Scale Mechanics of Cryopreserved Human Arterial Allografts Across a Six-Month Period.冷冻保存的人同种异体动脉移植物六个月期间的多尺度力学
J Funct Biomater. 2025 May 29;16(6):198. doi: 10.3390/jfb16060198.
2
Current State and Challenges of Tissue and Organ Cryopreservation in Biobanking.生物银行组织和器官低温保存的现状和挑战。
Int J Mol Sci. 2024 Oct 16;25(20):11124. doi: 10.3390/ijms252011124.
3
Breaking the Limit of Cardiovascular Regenerative Medicine: Successful 6-Month Goat Implant in World's First Ascending Aortic Replacement Using Biotube Blood Vessels.突破心血管再生医学的极限:世界首例使用生物管血管进行升主动脉置换的山羊植入手术成功进行6个月。
Bioengineering (Basel). 2024 Apr 20;11(4):405. doi: 10.3390/bioengineering11040405.
4
Use of a Silver-Impregnated Vascular Graft: Single-Center Experience.银浸渍血管移植物的应用:单中心经验。
Antibiotics (Basel). 2022 Mar 15;11(3):386. doi: 10.3390/antibiotics11030386.

本文引用的文献

1
Results of cryopreserved arterial allograft replacement for thoracic and thoracoabdominal aortic infections.冷冻保存动脉同种异体移植物置换治疗胸主动脉和胸腹主动脉感染的结果。
J Vasc Surg. 2021 Feb;73(2):626-634. doi: 10.1016/j.jvs.2020.05.052.
2
Cryopreserved Human Allografts for the Reconstruction of Aortic and Peripheral Prosthetic Graft Infection.用于主动脉和周围人工血管感染重建的低温保存人类同种异体移植物
Ann Vasc Dis. 2017 Dec 25;10(4):391-397. doi: 10.3400/avd.oa.17-00068.
3
Cryopreserved Cadaveric Arterial Allograft for Arterial Reconstruction in Patients with Prosthetic Infection.冷冻保存的尸体动脉同种异体移植物在假体感染患者中的动脉重建。
Eur J Vasc Endovasc Surg. 2017 Nov;54(5):636-644. doi: 10.1016/j.ejvs.2017.07.016. Epub 2017 Sep 7.
4
Reconstructions Following Graft Infection: An Unsolved Challenge.移植感染后的重建:一项未解决的挑战。
Eur J Vasc Endovasc Surg. 2017 Feb;53(2):151-152. doi: 10.1016/j.ejvs.2016.11.006. Epub 2016 Dec 20.
5
Diagnosis of Aortic Graft Infection: A Case Definition by the Management of Aortic Graft Infection Collaboration (MAGIC).主动脉移植物感染的诊断:主动脉移植物感染协作组(MAGIC)的病例定义
Eur J Vasc Endovasc Surg. 2016 Dec;52(6):758-763. doi: 10.1016/j.ejvs.2016.09.007. Epub 2016 Oct 19.
6
Late Fate of Cryopreserved Arterial Allografts.冷冻保存动脉同种异体移植物的远期转归
Eur J Vasc Endovasc Surg. 2016 Nov;52(5):696-702. doi: 10.1016/j.ejvs.2016.08.005. Epub 2016 Sep 7.
7
Recent Results of In Situ Abdominal Aortic Reconstruction with Cryopreserved Arterial Allograft.低温保存同种异体动脉原位腹主动脉重建的近期结果
Eur J Vasc Endovasc Surg. 2017 Feb;53(2):158-167. doi: 10.1016/j.ejvs.2016.07.090. Epub 2016 Sep 1.
8
In situ reconstruction in native and prosthetic aortic infections using cryopreserved arterial allografts.使用冷冻保存的动脉同种异体移植物原位重建原发性和假体主动脉感染。
Eur J Vasc Endovasc Surg. 2014 Sep;48(3):292-9. doi: 10.1016/j.ejvs.2014.04.023. Epub 2014 Jun 10.
9
The use of cryopreserved aortoiliac allograft for aortic reconstruction in the United States.美国使用冷冻保存的同种异体腹主动脉移植物进行主动脉重建。
J Vasc Surg. 2014 Mar;59(3):669-74. doi: 10.1016/j.jvs.2013.09.009. Epub 2013 Nov 14.
10
Homograft banking in Singapore: two years of cardiovascular tissue banking in Southeast Asia.新加坡的同种异体移植库:东南亚心血管组织库的两年历程。
Cell Tissue Bank. 2013 Jun;14(2):187-94. doi: 10.1007/s10561-012-9310-8. Epub 2012 Apr 27.

克罗地亚心血管组织库中冷冻保存血管同种异体移植物的十年经验。

Ten-year experience with cryopreserved vascular allografts in the Croatian Cardiovascular Tissue Bank.

作者信息

Golemovic M, Skific M, Haluzan D, Pavic P, Golubic Cepulic B

机构信息

Department of Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, Zagreb, Croatia.

Department of Surgery, Division for Vascular Surgery, University Hospital Centre Zagreb, Zagreb, Croatia.

出版信息

Cell Tissue Bank. 2022 Dec;23(4):807-824. doi: 10.1007/s10561-022-09992-6. Epub 2022 Feb 7.

DOI:10.1007/s10561-022-09992-6
PMID:35129755
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8818844/
Abstract

The Croatian Cardiovascular Tissue Bank (CTB) was established in June 2011. Activities managed by CTB are processing of heart valves and blood vessels, as well as quality control, storage, medical release and distribution of allografts. The aim of this report is to present CTB's vascular tissue activities and retrospectively evaluate the outcomes of their use in the University Hospital Centre Zagreb. Between June 2011 and July 2021, 90 vascular allografts (VAs) from 55 donors after brain death were referred to CTB. Only 54% of VAs met the tissue quality requirements while 46% of tissues were discarded. The most frequent reasons for discard were unacceptable morphology and initial microbiological contamination. Altogether 42 VAs were released for transplantation and 37 of them were used in 27 surgical procedures. The most common indication for surgery was prosthetic graft or stent infection. According to the anatomic position of vascular reconstruction, patients were divided in the aortic and peripheral reconstruction group. A total of 23 patients were treated. In the aortic reconstruction group 58% of patients did not experience any graft-related complications. In the group of patients who underwent peripheral reconstruction significant incidence of reinfection was observed highlighting it as a major graft-related complication. Despite the small patient groups and limited duration of follow-up, presented clinical outcomes provide valuable information on the efficacy of vascular allografts. Additional clinical results collected on a larger patient groups and comparison to other reconstructive treatment options are necessary.

摘要

克罗地亚心血管组织库(CTB)成立于2011年6月。CTB管理的活动包括心脏瓣膜和血管的处理,以及同种异体移植物的质量控制、储存、医学放行和分发。本报告的目的是介绍CTB的血管组织活动,并回顾性评估其在萨格勒布大学医院中心使用的结果。2011年6月至2021年7月期间,55例脑死亡供体的90个血管同种异体移植物(VA)被送至CTB。只有54%的VA符合组织质量要求,46%的组织被丢弃。最常见的丢弃原因是形态不可接受和初始微生物污染。共有42个VA被放行用于移植,其中37个用于27例外科手术。最常见的手术指征是人工血管移植物或支架感染。根据血管重建的解剖位置,患者被分为主动脉重建组和外周重建组。共有23例患者接受治疗。在主动脉重建组中,58%的患者未出现任何与移植物相关的并发症。在外周重建组的患者中,观察到再感染的发生率较高,这突出表明其是主要的与移植物相关的并发症。尽管患者群体较小且随访时间有限,但所呈现的临床结果为血管同种异体移植物的疗效提供了有价值的信息。有必要收集更大患者群体的更多临床结果,并与其他重建治疗选择进行比较。